<?xml version="1.0" encoding="UTF-8"?>
<p id="para0011">Although highly active antiretroviral therapy (HAART) has led to sustained decreases in HIV-related morbidity, mortality, and incidence 
 <xref rid="bib0001" ref-type="bibr">[1]</xref>, HIV transmission foci remain, even in developed countries 
 <xref rid="bib0002" ref-type="bibr">[2]</xref>, 
 <xref rid="bib0003" ref-type="bibr">[3]</xref>. Identifying areas at high risk of ongoing HIV transmission is critical for the efficient allocation of HIV prevention and treatment services to meet the UNAIDS 90-90-90 Targets 
 <xref rid="bib0004" ref-type="bibr">[4]</xref>. Population-level HIV drug resistance genotyping datasets, collected for strain surveillance and during routine clinical care, provide a unique molecular window into viral transmission 
 <xref rid="bib0003" ref-type="bibr">[3]</xref>. Indeed, phylogenetic inference of HIV transmission hot spots from existing resistance genotyping datasets represents a cornerstone of the United States' new strategy to end HIV 
 <xref rid="bib0005" ref-type="bibr">[5]</xref>.
</p>
